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 Abstract   
Hormonal, metabolic and immunological changes occurring during pregnancy have significant effects on the 
function of the skin. Psoriasis is one of the most common dermatological diseases and it is known as a nonspecific 
dermatosis in pregnancy. 
The aim of this article is to present the importance of support in the course of psoriasis in pregnant women. Psoriasis 
may cause recurrent miscarriages, chronic hypertension, diabetes or obesity, leading to perinatal complications and 
premature birth. The coexistence of psoriasis and pregnancy requires emotional prophylaxis, as well as support and 
psychotherapeutic care. Medical staff requires knowledge of skin diseases and skills to assess a patient’s mental 
state.
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 Streszczenie 
Zmiany hormonalne, metaboliczne oraz immunologiczne występujące w okresie ciąży w istotny sposób wpływają 
na funkcjonowanie skóry. Łuszczyca należy do najczęstszych schorzeń dermatologicznych i zaliczana jest do 
nieswoistych dermatoz okresu ciąży. 
Celem artykułu jest przedstawienie znaczenia wsparcia w przebiegu łuszczycy u kobiet ciężarnych. Ciąża w róż-
ny sposób wpływa na przebieg łuszczycy. Łuszczyca może powodować wystąpienie nawracających poronień, 
przewlekłego nadciśnienia tętniczego, cukrzycy, otyłości prowadząc do wystąpienia powikłań okołoporodowych 
i  porodu przedwczesnego. W  sytuacji stwierdzenia współistnienia łuszczycy w  ciąży konieczne jest wdrożenie 
profilaktyki w sferze emocjonalnej i objęcie ciężarnych wsparciem i opieką psychoterapeutyczną. Wspieranie cię-
żarnej z łuszczycą wymaga od personelu medycznego umiejętności oceny stanu psychicznego kobiety oraz wiedzy 
w zakresie chorób skóry.
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Admission
Although	 pregnancy	 is	 a	 physiological	 phenomenon,	 it	
is	 nevertheless	 a	 time	 of	 difficult	 and	 psychological	 biological	
adaptation.	 Hormonal,	 metabolic	 and	 immunological	 changes	
occurring	 in	pregnancy	have	significant	effects	on	 the	 function	
of	the	skin.	Psoriasis	is	one	of	the	most	common	dermatological	
diseases	 and	 belongs	 to	 the	 group	 of	 nonspecific	 dermatoses	
of	 pregnancy.	 Numerous	 studies	 on	 the	 negative	 influence	 of	
psoriasis	 in	 the	 course	 of	 pregnancy	 confirm	 that	 pregnant	
women	need	adequate	support	system.	A	high	level	of		support	
significantly	 decreases	 stress	 and	 anxiety,	 limiting	 the	 number	
of	 medical	 complications	 in	 pregnancy,	 and	 has	 a	 positive	
influence	on	patient	well-being.	Identification	of	quantitative	and	
qualitative	requirements	and	 the	source	of	support	 is	 important	
in	order	to	develop	a	holistic	model	of	care	for	pregnant	women	
with	psoriasis	[1,	2,	3,	4].
The aim 
The	aim	of	this	article	is	to	present	the	importance	of	support	
for	pregnant	patients	with	psoriasis.	
Characteristic of psoriasis
Psoriasis	is	classified	as	one	of	the	most	severe	dermatological	
diseases.	It	is	a	noninfectious,	chronic,	inflammatory	skin	disease	
of	 complex	 etiopathogenesis.	 Approximately	 1-3%	 of	 the	
European	 and	American	 population	 suffer	 from	psoriasis,	with	
about	one	million	people	affected	in	Poland	alone	[5,	6,	7,	8].
Although	psoriasis	does	not	endanger	the	lives	of	patients,	it	
may	cause	incapacity	for	work	and	lead	to	mental	and	physical	
disabilities.	 Psoriasis	 treatment	 does	 not	 eliminate	 the	 disease	
permanently	and	only	leads	to	remission	[1,	9,	10].	
This	disease	 is	characterized	by	a	variable	clinical	picture.	
Lesions	can	be	limited	to	the	most	typical	areas	of	the	body	or	
occupy	the	whole	surface	of	the	skin	and/or	affect	the	joints.	Two	
types	of	psoriasis	are	known:	type	1	–	with	onset	before	the	age	
of	40	and	a	more	severe	clinical	picture,	type	2	–	with	onset	after	
40	years	of	age	and	a	mild	course	of	the	disease	[11].	
A	burdensome	topical	treatment,	as	well	as	many	methods	of	
systemic	treatment	are	used,	but	each	of	them	has	its	limitations	
and	the	risk	of	potential	complications	[10,	12].
Numerous	 external	 and	 internal	 factors	 such	 as	 stress,	
changes	 in	 hormone	 levels	 mainly	 in	 pregnancy,	 menopause,	
trauma,	infections,	sun	radiation	and	drugs,	influence	the	clinical	
picture	of	psoriasis	[13].
Pregnancy and psoriasis
Sex	 hormones	 (estrogens,	 progesterone	 and	 androgens),	
have	 a	 biological	 and	 immunological	 impact	 on	 the	 skin	
pathophysiology,	 so	pregnancy	 influences	 the	natural	course	of	
psoriasis	[13].
Pregnancy	 affects	 the	 course	 of	 psoriasis	 in	 various	ways.	
The	literature	shows	that	reduction	of	symptoms	is	observed	in	
about	30-40%	of	women,	aggravation	of	symptoms	in	about	10-
25%	of	pregnancies	and	no	change	is	reported	in	about	20%	of	
cases	[5,	14,	15,	16].	
Raychaudhuri	et	al.,	reported	an	improvement	in	psoriasis	in	
55-56%	of	female	patients,	a	deterioration	in	23-26%	of	women,	
and	no	effect	in	18-21%.	In	another	study	by	Mowad	et	al.,	an	
improvement	was	noted	only	 in	4%	of	pregnant	women,	while	
in	41%	of	cases	the	pregnancy	had	a	negative	impact	on	the	skin	
condition	[17,	18].	
Immunological	changes	with	a	predominance	of	the	humoral	
response	 (Th2),	 the	 production	 of	 blocking	 antibodies	 and	
physiologically	 increased	 levels	 of	 progesterone	 and	 estrogens	
are	 the	main	 factors	 that	may	 affect	 the	 course	 of	 psoriasis	 in	
pregnancy	and	that	are	also	necessary	to	maintain	the	pregnancy	
[11].
In	 pregnancy,	 Th1-dependent	 diseases	 such	 as	 psoriasis	
may	 be	 improving	 due	 to	 an	 increase	 in	 the	 participation	 of	
Th2	cells	compared	 to	Th1,	 resulting	 in	an	 increased	synthesis	
of	 interleukins	 Th2	 (IL-4,	 IL-5,	 IL-6,	 IL-9,	 IL-10,	 IL-13)	 and	
reduction	 in	 the	 level	of	 interleukins	Th1	(IL-2,	 IL-12,	TNF-α,	
IFN-α).	
Therefore,	changes	in	the	immune	status	during	pregnancy	
weaken	the	Th1-dependent	process	of	psoriasis.	In	recent	years,	a	
significant	role	of	lymphocytes	Th17	in	the	course	of	psoriasis	has	
been	reported.	A	recent	study	of	Saito	et	al.,	reported	a	reduction	
of	Th1	and	Th17	cells	in	the	course	of	a	physiological	pregnancy.	
The	 results	 demonstrate	 a	 significant	 role	 of	Th17	 cells	 in	 the	
maintenance	of	pregnancy.	In	cases	when	the	level	of	Th17	cells	
in	peripheral	blood	is	stable	or	slightly	elevated,	and	rises	in	the	
uterus,	a	miscarriage	may	occur	[19].	There	are	also	hypotheses	
which	 suggest	 human	 placental	 lactogen	 and	 human	 chorionic	
gonadotropin	to	play	a	role	in	the	immunosuppressive	effect	of	
the	fetus	and	the	placenta	on	the	deficiency	system	of	a	pregnant	
woman	[15,	18,	19,	20].
The	effect	of	high	levels	of	estriol	and	progesterone	during	
pregnancy	on	the	course	of	the	disease	is	also	crucial.	Estrogen	
reduces	 the	 number	 of	 neutrophils	 and	 Th1	 cells,	 and	 the	
synthesis	 of	 chemokines	 by	 keratinocytes.	 The	 production	 of	
inflammatory	IL-12	and	TNF-α	is	inhibited	while	the	production	
of	anti-inflammatory	IL-10	is	increased.	Progesterone	stimulates	
Th2	cells	to	synthesize	IL-4	and	IL-5	and	the	transferring	protein	
(blocking	 factor),	what	has	 a	positive	effect	on	 the	 increase	of	
Th2	 cytokines	 production	 by	 peripheral	 blood	 lymphocytes	 of	
a	 pregnant	 woman.	As	 a	 result,	 reduced	 NK	 cell	 activity	 and	
increased	Th2-mediated	immune	response	are	observed	[21,	22].
On	the	other	hand,	psoriasis	can	cause	recurrent	miscarriages,	
chronic	 hypertension,	 diabetes	 or	 obesity,	 leading	 to	 perinatal	
complications	and	premature	birth.
Pregnancy	also	predisposes	to	impetigo	herpetiformis	(a	rare	
type	of	pustular	psoriasis)	–	a	severe	and	life-threatening	illness,	in	
which	the	skin	lesions	are	accompanied	by	systemic	symptoms	and	
abnormal	laboratory	results	-	fever,	leukocytosis,	hypocalcemia,	
or	symptoms	of	heart	failure.	Impetigo	herpetiformis	is	the	most	
common	 in	 the	 second	 trimester	 of	 pregnancy	 and	 can	 lead	 to	
fetal	death	or	preterm	delivery	[14,	23].
Treatment	of	psoriasis	in	pregnancy	is	individualized,	taking	
into	account	 the	extent	and	severity	of	 the	disease,	 the	benefits	
of	 therapy	 and	 the	 potential	 risk	 for	 the	mother	 and	 the	 fetus.	
Emollients	 and	 weak	 to	 moderately	 strong	 corticosteroids	 are	
used.	UVB	therapy	is	allowed	in	case	of	diffuse	lesions	[11].
Social support of pregnant women with 
psoriasis
Psychological	factors	greatly	influence	the	eruption	and	the	
course	of	psoriasis.	Aggravation	of	psoriatic	lesions	is	observed	
in	situations	of	psychological	and	physiological	stress	[24,	25].	
©  P o l s k i e  T o w a r z y s t w o  G i n e k o l o g i c z n eNr 03/2013 213
    położnictwo
P R A C E  P O G L Ą D O W EGinekol Pol. 2013, 84, 211-213 
Makara-Studzińska M, et al. Somatic and non-somatic problems connected with psoriasis in pregnancy.
Contemporary	 definition	 of	 psychological	 stress	 claims	 it	
involves	 external	 factors	 and	 the	 resulting	 consequences,	 the	
internal	factors:	anxiety,	emotional	tension.	Physiological	stress	
is	a	series	of	reactions	and	chemical	processes	whose	excess	is	
harmful	to	health	[26,27].
Pregnancy	 causes	 psychological	 stress,	 being	 associated	
with	 frustration,	 and	 leads	 to	 a	 number	 of	 internal	 conflicts.	 It	
is	 a	 source	of	 individual	 and	 social	pressures.	 It	 is	 a	period	of	
physical	 stress	associated	with	changes	 taking	place	within	 the	
endocrine,	immune	and	nervous	systems.	Pregnancy	can	change	
self-perception	 and	 cause	 lack	 of	 acceptance	 of	 the	 changing	
appearance	 what,	 accompanied	 by	 psoriatic	 lesions	 on	 the	
exposed	parts	of	the	body	or	the	genitals,	may	increase	discomfort	
and	lower	the	mood	[28,	29].
Psoriasis	in	pregnancy	can	cause	many	diseases	that	lead	to	
perinatal	complications	and	premature	births	[14].
Pregnancy	and	the	associated	mental	and	physical	burden	for	
the	 patient,	 as	well	 as	 the	 coexistence	 of	 psoriasis	which	may	
cause	complications	and	symptoms	such	as	itching,	lead	to	high	
levels	of	stress	and	call	for	support	and	psychoprevention	[25].
Support	 is	 a	 multidimensional	 term,	 with	 the	 exchange	
of	 emotional	 support,	 information,	 tools	 and	 assets	 as	 its	
characteristic	feature.	This	exchange	may	be	unilateral	or	bilateral,	
and	 its	 direction	 (giver	 –	 receiver)	 can	 be	 fixed	 or	 variable.	 It	
is	important	to	accurately	respond	to	the	needs	of	a	person	in	a	
difficult	situation.	Support	plays	an	key	role	in	neutralizing	the	
impact	of	negative	events	and	other	stressors	by	eliminating	or	
minimizing	 these	 stressors,	 improving	 the	 ability	 to	 cope	with	
stress,	reducing	the	effect	of	a	stressful	situation	after	an	incident.	
Support	also	lowers	the	level	of	stress,	 thus	helping	the	patient	
to	 cope	 with	 a	 difficult	 situation.	 Perception	 and	 availability	
of	 social	 support	 during	 a	 difficult	 situation	 is	 a	 key	 variable	
modulating	successful	coping	with	stress.	 In	order	 to	support	a	
pregnant	patient	with	psoriasis,	psychological	evaluation	of	 the	
mental	abilities	of	the	woman	and	knowledge	of	the	nature	of	the	
disease	are	required	[3,	4,	16,	28].	
Any	kind	of	support	 for	pregnant	women	with	psoriasis	 is	
essential:	instrumental	support	-	to	better	understand	the	course	
of	the	disease	during	pregnancy,	informative	support	–	to	provide	
the	 necessary	 information	 about	 how	 to	 live	 with	 the	 disease	
during	pregnancy,	and	evaluative	and	emotional	support	–	to	help	
relieve	tension,	reduce	discomfort	and	ensure	safety	[16,	28].
Offering	support	to	pregnant	women	with	psoriasis	may	lead	
to	their	acquisition	of	skills	how	to	deal	with	the	disease	during	
pregnancy	 and	 achieve	higher	 self-esteem.	 It	 can	 reduce	 stress	
levels,	 thereby	preventing	adverse	physiological	changes	in	the	
body	and	the	skin	[25].
Psychotherapy	in	the	treatment	of	psoriasis	is	mainly	based	
on		individual	psychotherapy,	group	psychotherapy,	meditation,	
relaxation	 techniques,	 autogenic	 training,	 or	 visualization.	The	
techniques	are	aimed	at	reducing	stress	and	improving	the	quality	
of	life	[30].
Summary
The	task	of	granting	a	pregnant	psoriatic	patient	emotional	
support,	 information,	 instrumental	 or	 tangible	 techniques,	 is	
interdisciplinary	 and	 challenging.	 It	 requires	 the	 medical	 staff	
to	be	able	 to	assess	 the	mental	 status	of	psoriatic	patients	and,	
most	 importantly,	 to	 have	 the	 knowledge	 about	 the	 disease	 in	
pregnancy.	It	is	important	to	teach	pregnant	women	how	to	deal	
with	negative	emotions,	and	mitigate	the	problems	occurring	in	
the	course	of	psoriasis	in	pregnancy.
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